1,433
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells

, , & ORCID Icon
Article: 2329372 | Received 25 Oct 2023, Accepted 07 Mar 2024, Published online: 17 Mar 2024

References

  • Achard V, PPOA, Omlin A, Zilli T, Fischer S. Metastatic Prostate Cancer: Treatment Options. Oncology. 2022;100(1):48–10. doi:10.1159/000519861.
  • Grozescu T, Popa F. Prostate cancer between prognosis and adequate/proper therapy. J Med Life. 2017;10(1):5–12.
  • Wasim S, Lee S-Y, Kim J. Complexities of prostate cancer. IJMS. 2022;23(22):14257. doi:10.3390/ijms232214257.
  • Banefelt J, Liede A, Mesterton J, Stålhammar J, Hernandez RK, Sobocki P, Persson B-E. Survival and clinical metastases among prostate cancer patients treated with androgen deprivation therapy in Sweden. Cancer Epidemiol. 2014;38(4):442–447. doi:10.1016/j.canep.2014.04.007.
  • Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer: a review. Jama-J Am Med Assoc. 2017;317(24):2532–42. doi:10.1001/jama.2017.7248.
  • Achard V, Putora PM, Omlin A, Zilli T, Fischer S. Metastatic Prostate Cancer: Treatment Options. Oncol-Basel. 2022;100(1):48–59. doi:10.1159/000519861.
  • Kim CJ, Dong L, Amend SR, Cho YK, Pienta KJ. The role of liquid biopsies in prostate cancer management. Lab Chip. 2021;21(17):3263–88. doi:10.1039/D1LC00485A.
  • Lin J, Nousome D, Jiang J, Chesnut GT, Shriver CD, Zhu K. Five-year survival of patients with late-stage prostate cancer: comparison of the military health system and the U.S. general population. Br J Cancer. 2023;128(6):1070–76. doi:10.1038/s41416-022-02136-3.
  • Sena LA, Denmeade SR. Fatty acid synthesis in prostate cancer: vulnerability or epiphenomenon? Cancer Res. 2021;81(17):4385–93. doi:10.1158/0008-5472.CAN-21-1392.
  • Wang X, Shi X, Lu H, Zhang C, Li X, Zhang T, Shen J, Wen J. Succinylation inhibits the enzymatic hydrolysis of the extracellular matrix protein fibrillin 1 and promotes gastric cancer progression. Ad Sci. 2022;9(27):e2200546. doi:10.1002/advs.202200546.
  • Wang Y, Zhao L, Geng Y, Yuan H, Hou C, Zhang H, Yang G, Zhang X. Aspirin modulates succinylation of PGAM1K99 to restrict the glycolysis through NF-κB/HAT1/PGAM1 signaling in liver cancer. Acta Pharmacol Sin. 2023;44(1):211–220. doi:10.1038/s41401-022-00945-z.
  • Zhang Z, Chen Y, Fang L, Zhao J, Deng S. The involvement of high succinylation modification in the development of prostate cancer. Front Oncol. 2022. 12:1034605. doi:10.3389/fonc.2022.1034605.
  • Liu C Liu, Liu Y, Chen L, Zhang M, Li W, Cheng H, Zhang B. Quantitative proteome and lysine succinylome analyses provide insights into metabolic regulation in breast cancer. Emerg Cancer Ther. 2019;26(1):93–105. doi:10.1007/s12282-018-0893-1.
  • Liu J, Shangguan Y, Tang D, Dai Y. Histone succinylation and its function on the nucleosome. J Cell Mol Med. 2021;25(15):7101–7109. doi:10.1111/jcmm.16676.
  • Zhao G, Zhen J, Liu X, Guo J, Li D, Xie J, Xie L. Protein post-translational modification by lysine succinylation: biochemistry, biological implications, and therapeutic opportunities. Genes Dis. 2022;10(4):1242–1262. doi:10.1016/j.gendis.2022.03.009.
  • Lu K, Han D. A review of the mechanism of succinylation in cancer. Med (Baltimore). 2022;101(45):e31493. doi:10.1097/MD.0000000000031493.
  • Xu H, Wu M, Ma X, Huang W, Xu Y. Function and mechanism of novel histone posttranslational modifications in health and disease. Biomed Res Int. 2021. 2021:1–13. doi:10.1155/2021/6635225.
  • Schlaepfer IR, Joshi M. CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential. Endocrinology. 2020;161(2). doi:10.1210/endocr/bqz046.
  • Li Z, Zhang H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci. 2016;73(2):377–92. doi:10.1007/s00018-015-2070-4.
  • Bonnefont JP Dfpc. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med. 2004;25(5–6): 495–520.10.1016/j.mam.2004.06.004
  • KAT2A Is a α-KGDH–Dependent Histone Succinyltransferase. Cancer Discov. 2018;82:138. 10.1158/2159-8290.CD-RW2017-234.
  • Kurmi K, Hitosugi S, Wiese EK, Boakye-Agyeman F, Gonsalves WI, Lou Z, Karnitz LM, Goetz MP, Hitosugi T. Carnitine Palmitoyltransferase 1A has a Lysine Succinyltransferase Activity. Cell Rep. 2018;22(6):1365–1373. doi:10.1016/j.celrep.2018.01.030.
  • Rios-Colon L, Kumar P, Kim S, Sharma M, Su Y, Kumar A, Singh S, Stocks N, Liu L, Joshi M, et al. Carnitine Palmitoyltransferase 1 Regulates Prostate Cancer Growth under Hypoxia. CANCERS. 2021; 13(24):6302. doi:10.3390/cancers13246302.
  • Joshi M, Stoykova GE, Salzmann-Sullivan M, Dzieciatkowska M, Liebman, LN, Deep, G and Schlaepfer, IR. CPT1A supports castration-resistant prostate cancer in androgen-deprived conditions. CELLS-BASEL. 2019;8(10):1115. doi:10.3390/cells8101115.
  • Stoykova GE, Schlaepfer IR. Lipid metabolism and endocrine resistance in prostate cancer, and new opportunities for therapy. Int J Mol Sci. 2019;20(11):2626. doi:10.3390/ijms20112626.
  • Joshi M Joshi, Kim J, D’Alessandro A, Monk E, Bruce K, Elajaili H, Nozik-Grayck E, Goodspeed A, Costello JC, Schlaepfer IR. CPT1A over-expression increases reactive oxygen species in the mitochondria and promotes antioxidant defenses in prostate cancer. Cancers. 2020;12(11):3431. doi:10.3390/cancers12113431.
  • Liang K. Mitochondrial CPT1A: insights into structure, function, and basis for drug development. Front Pharmacol. 2023. 14:1160440. doi:10.3389/fphar.2023.1160440.
  • Tang M Tang, Dong X, Xiao L, Tan Z, Luo X, Yang L, Li W, Shi F, Li Y, Zhao L. CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma. Cell Death Disease. 2022;13(4):331. doi:10.1038/s41419-022-04730-y.
  • Tian T Tian, Lu Y, Lin J, Chen M, Qiu H, Zhu W, Sun H, Huang J, Yang H, Deng W. CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis. Redox Biol. 2022. 58:102544. doi:10.1016/j.redox.2022.102544.
  • Wang C Wang, Zhang C, Li X, Shen J, Xu Y, Shi H, Mu X, Pan J, Zhao T, Li M. CPT1A-mediated succinylation of S100A10 increases human gastric cancer invasion. J Cell Mol Med. 2019;23(1):293–305. doi:10.1111/jcmm.13920.
  • Zhu Y Zhu, Wang Y, Li Y, Li Z, Kong W, Zhao X, Chen S, Yan L, Wang L, Tong Y. Carnitine palmitoyltransferase 1A promotes mitochondrial fission by enhancing MFF succinylation in ovarian cancer. Commun Biol. 2023;6(1):618. doi:10.1038/s42003-023-04993-x.
  • KA C, Guérard K-P, Ejdelman J, Chevalier S, Yoshimoto M, Scarlata E, Fazli L, Sircar K, Squire JA, Brimo F. The 16p13.3 (PDPK1) genomic gain in prostate cancer: a potential role in disease progression. Transl Oncol. 2012;5(6):453–460. doi:10.1593/tlo.12286.
  • Nalairndran G Nalairndran, Hassan Abdul Razack A, Mai C-W, Fei‐Lei Chung F, Chan K-K, Hii L-W, Lim W-M, Chung I, Leong C-O. Phosphoinositide-dependent Kinase-1 (PDPK1) regulates serum/glucocorticoid-regulated Kinase 3 (SGK3) for prostate cancer cell survival. J Cell Mol Med. 2020;24(20):12188–12198. doi:10.1111/jcmm.15876.